ANTX
#3727
AN2 Therapeutics, Inc. - Common Stock
4.7 6 USD
+0.05%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+4.62%
Variación mensual
-3.45%
Variación en los últimos 6 meses
+274.80%
Cambio anual
+349.06%
Cierres anteriores
4.5 5
Open
4.7 6
Mínimo
4.7 6
High
4.7 6
Volumen
74
Financials
- Market Capitalization 171.44 M
- Employee 21
- Founded 2017
- CEO N/A
- Website www.an2therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QYLYBK4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3715 |  EQ Equillium, Inc. - Common Stock | 2.76 USD | -4.17% | -2.82% | -2.13% | +607.69% | 174.51 M USD | ||
| 3719 |  CRBU Caribou Biosciences, Inc. - Common Stock | 1.75 USD | -2.78% | -7.41% | +5.42% | +5.42% | 173.57 M USD | ||
| 3730 |  ADAG Adagene Inc - ADS, each representing 1.25 | 3.61 USD | -5.50% | -8.38% | +1.40% | +103.95% | 171.06 M USD | ||
| 3731 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.82 USD | +1.68% | -0.55% | -1.09% | +1.11% | 170.57 M USD |